Diasome Pharmaceuticals' Series C Round

Diasome Pharmaceuticals raised a round of funding on July 05, 2017.

Diasome Pharmaceuticals is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. Based on more than thirty years of research and development in the fie…

Articles about Diasome Pharmaceuticals' Series C Round: